Xanthelasmahttps://en.wikipedia.org/wiki/Xanthelasma
Xanthelasma se yon depo kolestewòl jòn ki byen delimite anba po a. Li anjeneral rive sou oswa alantou po je yo. Pandan ke yo pa ni danjere pou po a ni fè mal, ti kwasans sa yo ka defigire epi yo ka retire. Gen yon kantite prèv k ap grandi pou asosyasyon ki genyen ant xanthelasma ak nivo lipoprotein ba-dansite nan san ak ogmante risk pou ateroskleroz.

Tretman
Ti blesi yo ka trete ak lazè, men repetisyon trè komen.

☆ Nan rezilta Stiftung Warentest 2022 ki soti nan Almay, satisfaksyon konsomatè yo ak ModelDerm te sèlman yon ti kras pi ba pase ak konsiltasyon telemedsin peye.
  • Li karakterize pa simetri bilateral. Repetisyon an komen menm apre tretman lazè.
  • Xanthelasma palpebrarum
References Xanthelasma Palpebrarum 30285396 
NIH
Xanthelasma palpebrarum se yon kondisyon kote depo ki mou, ki gen anpil kolestewòl fòme boul jòn oswa plak sou kwen enteryè nan po je yo. Li se benign epi li pa poze gwo risk pou sante. Apeprè mwatye nan adilt ki gen xanthelasma gen nivo lipid nòmal. Nan pi piti moun, espesyalman timoun, wè xanthelasma ta ka sijere yon maladi lipid eritye. Tretman pou xanthelasma anjeneral se pou rezon kosmetik, paske anjeneral li pa nesesè pou rezon medikal.
Xanthelasma palpebrarum is primarily characterized by soft, lipid-rich deposits, especially cholesterol, manifesting as semisolid, yellowish papules or plaques. These deposits are typically found on the inner aspect of the eyes and are most commonly located along the corners of the upper and lower eyelids. Xanthelasma palpebrarum is a benign lesion and does not pose significant health risks. Approximately 50% of adult patients with xanthelasma have abnormal lipid levels. In younger individuals, particularly children, the presence of xanthelasma should prompt consideration of an underlying inherited dyslipidemia. Although xanthelasma treatment is typically not medically necessary, some patients may seek therapy for cosmetic reasons.